Cryo-Cell International Inc. (NYSEAMERICAN:CCEL – Get Free Report) shares dropped 10.2% during mid-day trading on Friday. The stock traded as low as $4.34 and last traded at $4.85. Approximately 14,208 shares were traded during trading, an increase of 68% from the average session volume of 8,440 shares. The stock had previously closed at $5.40.
Cryo-Cell International Stock Performance
The business’s fifty day moving average price is $4.47 and its 200-day moving average price is $3.76. The stock has a market cap of $39.09 million, a PE ratio of -21.09 and a beta of 0.45.
Cryo-Cell International (NYSEAMERICAN:CCEL – Get Free Report) last announced its quarterly earnings results on Friday, October 9th. The company reported $0.16 EPS for the quarter. The company had revenue of $7.82 million during the quarter.
Institutional Investors Weigh In On Cryo-Cell International
An institutional investor recently raised its position in Cryo-Cell International stock. Susquehanna International Group LLP increased its stake in Cryo-Cell International Inc. (NYSEAMERICAN:CCEL – Free Report) by 40.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,064 shares of the company’s stock after purchasing an additional 4,046 shares during the quarter. Susquehanna International Group LLP owned 0.17% of Cryo-Cell International worth $45,000 at the end of the most recent quarter. Institutional investors and hedge funds own 10.44% of the company’s stock.
Cryo-Cell International Company Profile
Cryo-Cell International, Inc. is a biotechnology and healthcare services company that provides stem cell collection, processing and long-term cryogenic storage. The company primarily focuses on preserving umbilical cord blood and cord tissue, which contain stem cells that may be used in certain medical treatments and regenerative medicine applications. Its services are marketed primarily to expectant parents and families through private biological material banking programs. Cryo-Cell provides collection kits, coordination with healthcare professionals, laboratory processing and secure storage services.
Further Reading
- Five stocks we like better than Cryo-Cell International
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with MarketBeat.com's FREE daily email newsletter.
